Get trusted answers for your mental health

What clinical information does a GP typically need before agreeing to Shared Care?

In the UK, there is no single national checklist that every GP follows for shared care of ADHD medication. Policies vary by local NHS area and individual GP practices. However, GPs will generally want enough information to be confident that specialist assessment, prescribing, and monitoring have been carried out appropriately before taking over repeat prescribing. Normally the GP will want a clinic letter from us of sufficient detail and quality that they are assured of: -The diagnostic criteria used (such as DSM-5 or ICD-11). -A summary of the assessment. -Relevant psychiatric, developmental, and medical history. -The medication prescribed (name, formulation, and dose) and why was that chose. -How the dose was titrated. -The current stable dose and for how long they have been on it -Evidence that titration is complete, showing: Symptoms have improved. Side effects are acceptable. The dose has been stable for an appropriate period.A clear shared care agreement, setting out: What the specialist remains responsible for. What the GP is expected to do. How often reviews are required. How concerns or dose changes will be managed. Even when all of the above information is provided, a GP is not obliged to enter into a shared care agreement. They may decline because: • Their practice policy does not support shared care for ADHD. • Their local ICB guidance restricts it. • They feel they lack the expertise or capacity to monitor the medication safely. • The specialist is outside the NHS or not recognised under local arrangements. If your specialist is requesting shared care, it can help if they provide a comprehensive clinic letter addressing all of the points above, together with the local shared care protocol if one exists. This often makes it easier for the GP to assess whether they are able to take over prescribing.

James White

Nurse Practitioner

2026-08-25 09:14

0 views

What details does a clinician usually include in a letter supporting workplace or school accommodations?

So workplace and school accomadations are a specific bit of practice for Occupational health, and while we can advise and offer our support we cannot dictate to an employer or school .typical information we would include is: • Clinician details: name, professional role/registration, organisation, and contact details. • Patient details: name and sometimes date of birth or other identifier. • Diagnosis: confirmation that the person has ADHD, if the clinician is able and willing to disclose it. • Clinical basis: briefly indicate that the diagnosis has been assessed/established, without unnecessarily including confidential medical history. • Functional difficulties: how ADHD affects the person in the relevant setting, for example: o sustaining attention during lengthy tasks or meetings o organising and prioritising work o managing time and deadlines o working in distracting environments o processing or remembering verbal instructions o switching between tasks • o maintaining concentration during exams or other assessments • The resulting disadvantage: ideally, explain what happens without support—for example, difficulty demonstrating knowledge in timed assessments or difficulty completing tasks in an open-plan environment. • Recommended adjustments: specific, practical measures linked to those difficulties. Depending on the setting, this might include written instructions, breaking larger tasks into stages, reduced-distraction workspace, additional exam time, rest breaks, assistive technology, or flexibility around scheduling. • Duration/review: whether the recommendations are expected to be ongoing and when they should be reviewed. • Clinician's opinion: wording such as “In my clinical opinion, these adjustments would help reduce the functional difficulties associated with ADHD.”

James White

Nurse Practitioner

2026-08-25 09:14

0 views

What information does a pharmacist typically check before dispensing a controlled ADHD medication?

1. The prescription is legally valid o Patient's name and address o Date of prescription o Prescriber's details and authority o Medicine, formulation and strength o Dose and directions o Total quantity, including the quantity expressed appropriately in words and figures where required 2. Appropriate prescriber authentication/signature. The prescription is within the controlled-drug time limit (28 days) 3. The medicine and dose make clinical sense The pharmacist checks the prescribed product, strength, formulation and dose, including whether a modified-release product is appropriate. This matters particularly with methylphenidate because different modified-release brands can have different release profiles. 4. Potential interactions and safety issues They may review the patient's other medicines and relevant clinical information for interactions, contraindications or concerns. ADHD treatment is also normally monitored for things such as blood pressure, pulse, weight and adverse effects, although much of this monitoring is generally undertaken by the prescriber rather than at every dispensing. 5. Whether anything unusual needs clarification 6. If the prescription contains an apparent error, unusual dose, unclear instructions, or another concern, the pharmacist may contact the prescriber before dispensing. They have specific legal constraints on what can be amended on a controlled-drug prescription. Collection/identity requirements When a controlled medicine is collected, the pharmacist may ask for proof of identity, particularly for Schedule 2 controlled drugs. If somebody else collects it, they may need to provide identifying information and/or identification. 7. Supply and stock The pharmacy also has to ensure it has the correct medicine and quantity available and maintain the required controlled-drug records. Schedule 2 supplies are subject to additional record-keeping requirements

James White

Nurse Practitioner

2026-08-25 09:14

0 views